Acquired infection is one of the most prevalent sources of concern in neonatal intensive care units (NICUs). Center-to-center variation has been noted by both the National Nosocomial Infection Surveillance System and the Vermont Oxford Network suggesting that site of care influences outcomes including acquired infection.
INTRODUCTION
Structured neonatal intensive care units (NICU) quality improvement (QI) has been driven by the recognition of variation in practice and outcomes. QI methods range from local isolated rapid cycle change to broadscale networks using an evidence-based approach. 1 Best demonstrated process (BDP) 2 is a methodology adapted to healthcare by one of us (AC). The unique concept of BDP is the contrast of observed process level variations between high and low performance centers. If the outcomes being measured are influenced by how care is provided, implementation of these meaningful differences should improve performance and ultimately outcomes.
Acquired infection is a source of concern in many NICUs. 3 Infants with acquired infection, spend more days on mechanical ventilation, have longer hospital stays, have higher costs associated with their care and a higher mortality rate when compared to those who are free of infection throughout their stay. 4 Based upon previously reported center-to-center variation, 1, 5, 6 we postulated that acquired infection would be a successful target for our first neonatal BDP project.
METHODS

Best Demonstrated Process
A site visit team was assembled from neonatal care providers, physicians, nurses and respiratory care practitioners (all included as authors). The team performed a critical appraisal of the literature related to the etiology, pathogenesis and risk factors for acquired infection. Exploring the available evidence, the team agreed that raw blood culture data needed to be adjusted for known influences such as birth weight and postmenstrual age. The final measure, episodes per 1000 patient days was chosen because length of stay is linked to both postmenstrual age at birth and birth weight. With the measurement and its adjustments agreed upon by the site visit team, the infection rate was measured for each NICU. NICUs in the upper and lower thirds (i.e. <33rd percentile and >66th percentile) of the performance curve were selected for site visits. The units selected also represent a balance of large and small units, based upon average daily census.
The site visit team constructed an observation guide with processes and subordinate processes, which might influence acquired infection. The guide was developed by the team who constructed an extensive flow chart of NICU processes, and then creating specific points to observe at each site. Eight observers were each sent, without knowledge of the site's performance, to one high and one low infection center. They observed for a period of not less than 24 hours.
The team met again after the site visits, and in detailed discussions, isolated meaningful differences (Table 1 ; parts a-e). Meaningful differences are those processes observed in all or virtually all the low sites and none or virtually none of the high or vice versa.
The meaningful differences, an explanation of the methodology and expectations were shared with the NICU Medical and Nursing Directors within the HCA system. No incentive or negative reinforcement was provided. However, the observation team expressed an expectation for centers in the lower third to move to the mean of the network, middle third centers to move to the average of the upper third and the upper third to maintain their performance or make modest improvements.
The Measurement
Blood culture data and daily census data from 52 NICUs in the HCA network were obtained by retrospective review of unit census materials, patient records and laboratory culture logs for a 12-month period ending June 1997. Infection episodes were defined by a positive bacterial blood culture collected after 3 days of age. It was reported as infection episodes per 1000 patient days (multiple positive cultures during a single episode were counted as one episode). For the follow-up period, each NICU admission and their acquired infection status was registered through the HCA Neonatal Outcomes Measurement and Improvement database. The postimplementation period was defined as September 1, 1998 through December 31, 1999.
Case-matched Series
We identified 68 matched pairs at one site as a subset of the preand post-implementation population at one center (Wesley Medical Center, the demonstration site). In all, 34 infants from the preimplementation period were matched one-to-one for gestational age (same week) and birth weight (within 50 g) with one infant in the postimplementation period. Hospital charges were converted to costs using the departmental cost-to-charge ratios from the applicable Medicare cost report. 7 
RESULTS
In the baseline period, the network infection rate was 3.8 (range 0 to 23) episodes per 1000 patient days. The demonstration site's rate was 7.4 episodes per 1000 patient days. The lower third of centers range was 0 to 2 (mean 0.5), 2 to 6 (mean 3.4) for the middle third and 6 to 23 (mean 10.5) episodes per 1000 patient days for the upper third. In the postimplementation period, the network infection rate was 3.0 per 1000 patient days (down from 3.8). The demonstration site's infection rate was 4.0 episodes per 1000 patient days (down from 7.4). In the series of 68 case-matched infants (Table 2) , the average hospital charge was reduced from $272,348 to $220,044 and the average total cost was reduced from $60,826 to $48,916 per infant. None of the demonstration site's improvements reached statistical significance because of sample size.
DISCUSSION
Best Demonstrated Process offers a new perspective and method for QI in a clinical network. It is founded on the premise that it is not just ''what'' we chose to do, but ''how'' we perform those interventions. Our work demonstrates that a network may benefit from BDP by a shift in performance in a relatively short time period.
There are several shortcomings in this, our first, neonatal BDP project. We did not track which of the meaningful differences were implemented in each site. Therefore, impact of any one specific meaningful difference will remain uncertain. A second round of observations, using newly ranked high and low sights, after implementation of the first set of meaningful differences, might also enhance our understanding. We also recognize that other important risk factors may have shifted over time and accounted for a portion of the reduction in acquired infection. We attempted Bloom et al. Reducing Acquired Infections in the NICU to address this concern by using case-matched controls within the demonstration site. The case-matched series lacked statistical power to reach a conclusion, but we did note a consistent direction and magnitude of change. And finally, we only modified the measurement by adjusting for length of stay. This was used as a proxy for risk and exposure, but may not account for the variable influence of site on different populations of patients. In the other work, we have noted that centers in the upper and lower thirds typically do not move out of these ranges even after adjustments for demographic and coexisting disease states. 8 If adjustment changes a site's performance ranking enough to move it across the boundaries of the upper or lower thirds, it is not used for a site visit. For our future work to reach statistical significance, we will need a large prospectively acquired data set, tracking of implementation, follow-up capability and the cooperation of multiple centers within a network.
CONCLUSION
Isolation of meaningful differences between high-and lowperformance centers and subsequent implementation may result in significant improvements in the outcome of clinical care. Reductions in length of stay, charges and costs are consistent with previous reports, but did not reach statistical significance in this sample. For quality improvement projects to reach statistical significance, multiple centers will have to pool their efforts.
